From: <Saved by Windows Internet Explorer 7>
Subject: /humansubjects/guidance/ documents
Date: Wed, 23 Apr 2008 13:24:47 -0400
MIME-Version: 1.0
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3198

=EF=BB=BF<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>/humansubjects/guidance/ documents</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<META content=3Dproduction name=3D"Document Status">
<META content=3Dbelmont.htm name=3DFilename>
<META content=3D"Larry Niemoeller" name=3DAuthor>
<META content=3D07/21/2000 name=3D"Last update">
<META content=3D"Larry Niemoeller" name=3D"Last update by">
<META content=3D"OHRP:OPRR:DPA:Guidance:Human Subject Protection:Belmont =
Report"=20
name=3DKeywords>
<META content=3D"Belmont Report" name=3DTitle>
<META content=3D"Belmont Report" name=3DDescription>
<SCRIPT language=3DJavaScript>=0A=
// Start Standard Status Message Reset=0A=
function setStatus(msg) {=0A=
        status =3D msg=0A=
        return true=0A=
}=0A=
// End Standard Status Message Reset=0A=
window.defaultStatus =3D "Please monitor What's New page for OHRP =
changes."=0A=
</SCRIPT>

<META content=3D"MSHTML 6.00.6000.16640" name=3DGENERATOR></HEAD>
<BODY aLink=3D#660000 link=3D#660000 bgColor=3D#ffffff><!-- Note that =
#FFFFFF specifies white (R=3D256, G=3D256, B=3D256), and that #660000 =
specifies brown (R=3D102, G=3D0, B=3D0) --><!-- Top Of Main Page -->
<H3>
<CENTER>The Belmont Report <BR><BR>Office of the Secretary =
<BR><BR>Ethical=20
Principles and Guidelines for the Protection of Human <BR>Subjects of =
Research=20
<BR><BR>The National Commission for the Protection of Human Subjects =
<BR>of=20
Biomedical and Behavioral Research<BR><BR>April 18, =
1979<BR></H3></CENTER>
<HR>

<P><B>AGENCY: </B>Department of Health, Education, and Welfare.=20
<P><B>ACTION: </B>Notice of Report for Public Comment.=20
<P><B>SUMMARY:</B> On July 12, 1974, the National Research Act (Pub. L. =
93-348)=20
was signed into law, there-by creating the National Commission for the=20
Protection of Human Subjects of Biomedical and Behavioral Research. One =
of the=20
charges to the Commission was to identify the basic ethical principles =
that=20
should underlie the conduct of biomedical and behavioral research =
involving=20
human subjects and to develop guidelines which should be followed to =
assure that=20
such research is conducted in accordance with those principles. In =
carrying out=20
the above, the Commission was directed to consider: <B>(i)</B> the =
boundaries=20
between biomedical and behavioral research and the accepted and routine =
practice=20
of medicine, <B>(ii)</B> the role of assessment of risk-benefit criteria =
in the=20
determination of the appropriateness of research involving human =
subjects,=20
<B>(iii)</B> appropriate guidelines for the selection of human subjects =
for=20
participation in such research and <B>(iv)</B> the nature and definition =
of=20
informed consent in various research settings.=20
<P>The Belmont Report attempts to summarize the basic ethical principles =

identified by the Commission in the course of its deliberations. It is =
the=20
outgrowth of an intensive four-day period of discussions that were held =
in=20
February 1976 at the Smithsonian Institution's Belmont Conference Center =

supplemented by the monthly deliberations of the Commission that were =
held over=20
a period of nearly four years. It is a statement of basic ethical =
principles and=20
guidelines that should assist in resolving the ethical problems that =
surround=20
the conduct of research with human subjects. By publishing the Report in =
the=20
Federal Register, and providing reprints upon request, the Secretary =
intends=20
that it may be made readily available to scientists, members of =
Institutional=20
Review Boards, and Federal employees. The two-volume Appendix, =
containing the=20
lengthy reports of experts and specialists who assisted the Commission =
in=20
fulfilling this part of its charge, is available as DHEW Publication No. =
(OS)=20
78-0013 and No. (OS) 78-0014, for sale by the Superintendent of =
Documents, U.S.=20
Government Printing Office, Washington, D.C. 20402.=20
<P>Unlike most other reports of the Commission, the Belmont Report does =
not make=20
specific recommendations for administrative action by the Secretary of =
Health,=20
Education, and Welfare. Rather, the Commission recommended that the =
Belmont=20
Report be adopted in its entirety, as a statement of the Department's =
policy.=20
The Department requests public comment on this recommendation.<BR><BR>
<HR>

<CENTER>
<H3>National Commission for the Protection of Human Subjects<BR>of =
Biomedical=20
and Behavioral Research</H3></CENTER>
<CENTER>
<H3>Members of the Commission</CENTER></H3>
<DL>
  <DT>
  <DD><I>Kenneth John Ryan, M.D., Chairman, Chief of Staff, Boston =
Hospital for=20
  Women.</I>=20
  <DT>
  <DD><I>Joseph V. Brady, Ph.D., Professor of Behavioral Biology, Johns =
Hopkins=20
  University.</I>=20
  <DT>
  <DD><I>Robert E. Cooke, M.D., President, Medical College of =
Pennsylvania.</I>=20
  <DT>
  <DD><I>Dorothy I. Height, President, National Council of Negro Women, =
Inc.</I>=20

  <DT>
  <DD><I>Albert R. Jonsen, Ph.D., Associate Professor of Bioethics, =
University=20
  of California at San Francisco.</I>=20
  <DT>
  <DD><I>Patricia King, J.D., Associate Professor of Law, Georgetown =
University=20
  Law Center.</I>=20
  <DT>
  <DD><I>Karen Lebacqz, Ph.D., Associate Professor of Christian Ethics, =
Pacific=20
  School of Religion.</I>=20
  <DT>
  <DD>*** <I>David W. Louisell, J.D., Professor of Law, University of =
California=20
  at Berkeley.</I>=20
  <DT>
  <DD><I>Donald W. Seldin, M.D., Professor and Chairman, Department of =
Internal=20
  Medicine, University of Texas at Dallas.</I>=20
  <DT>
  <DD>***<I>Eliot Stellar, Ph.D., Provost of the University and =
Professor of=20
  Physiological Psychology, University of Pennsylvania.</I>=20
  <DT>
  <DD>*** <I>Robert H. Turtle, LL.B., Attorney, VomBaur, Coburn, Simmons =
&amp;=20
  Turtle, Washington, D.C.</I><BR><BR>
  <DD><A name=3Dxrefer>***</A> <I>Deceased.</I> </DD></DL>
<HR>
<A name=3Dtoc></A>
<P>
<CENTER>
<H3>Table of Contents</CENTER><BR></H3>
<DL>
  <DD><A=20
  =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xethic=
al">Ethical=20
  Principles and Guidelines for Research Involving Human Subjects</A> =
</DD></DL>
<DL>
  <DD><A=20
  =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xbound=
">A.=20
  Boundaries Between Practice and Research</A></DD></DL>
<DL>
  <DD><A=20
  =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xbasic=
">B.=20
  Basic Ethical Principles</A></DD></DL>
<DL>
  <DL>
    <DD><A=20
    =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xrespe=
ct">1.=20
    Respect for Persons</A>=20
    <DD><A=20
    =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xbenef=
it">2.=20
    Beneficence</A>=20
    <DD><A=20
    =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xjust"=
>3.=20
    Justice</A></DD></DL></DL>
<DL>
  <DD><A=20
  =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xapp">=
C.=20
  Applications</A></DD></DL>
<DL>
  <DL>
    <DD><A=20
    =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xinfor=
m">1.=20
    Informed Consent</A>=20
    <DD><A=20
    =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xasses=
s">2.=20
    Assessment of Risk and Benefits</A>=20
    <DD><A=20
    =
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#xselec=
t">3.=20
    Selection of Subjects</A> </DD></DL></DL>
<P>
<HR>

<H3>
<CENTER><A name=3Dxethical>Ethical Principles &amp; Guidelines for =
Research=20
Involving Human Subjects</A></CENTER></H3>
<P>Scientific research has produced substantial social benefits. It has =
also=20
posed some troubling ethical questions. Public attention was drawn to =
these=20
questions by reported abuses of human subjects in biomedical =
experiments,=20
especially during the Second World War. During the Nuremberg War Crime =
Trials,=20
the Nuremberg code was drafted as a set of standards for judging =
physicians and=20
scientists who had conducted biomedical experiments on concentration =
camp=20
prisoners. This code became the prototype of many later codes<A =
name=3Dback1><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#go1">(=
1)</A></A>=20
intended to assure that research involving human subjects would be =
carried out=20
in an ethical manner.=20
<P>The codes consist of rules, some general, others specific, that guide =
the=20
investigators or the reviewers of research in their work. Such rules =
often are=20
inadequate to cover complex situations; at times they come into =
conflict, and=20
they are frequently difficult to interpret or apply. Broader ethical =
principles=20
will provide a basis on which specific rules may be formulated, =
criticized and=20
interpreted.=20
<P>Three principles, or general prescriptive judgments, that are =
relevant to=20
research involving human subjects are identified in this statement. =
Other=20
principles may also be relevant. These three are comprehensive, however, =
and are=20
stated at a level of generalization that should assist scientists, =
subjects,=20
reviewers and interested citizens to understand the ethical issues =
inherent in=20
research involving human subjects. These principles cannot always be =
applied so=20
as to resolve beyond dispute particular ethical problems. The objective =
is to=20
provide an analytical framework that will guide the resolution of =
ethical=20
problems arising from research involving human subjects.=20
<P>This statement consists of a distinction between research and =
practice, a=20
discussion of the three basic ethical principles, and remarks about the=20
application of these principles.<BR><BR><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#toc">[=
RETURN TO=20
TABLE OF CONTENTS]</A>=20
<HR>

<H3>
<CENTER><A name=3Dxbound>Part A: Boundaries Between Practice &amp;=20
Research</A></CENTER></H3>
<P><B>A. Boundaries Between Practice and Research</B>=20
<P>It is important to distinguish between biomedical and behavioral =
research, on=20
the one hand, and the practice of accepted therapy on the other, in =
order to=20
know what activities ought to undergo review for the protection of human =

subjects of research. The distinction between research and practice is =
blurred=20
partly because both often occur together (as in research designed to =
evaluate a=20
therapy) and partly because notable departures from standard practice =
are often=20
called "experimental" when the terms "experimental" and "research" are =
not=20
carefully defined.=20
<P>For the most part, the term "practice" refers to interventions that =
are=20
designed solely to enhance the well-being of an individual patient or =
client and=20
that have a reasonable expectation of success. The purpose of medical or =

behavioral practice is to provide diagnosis, preventive treatment or =
therapy to=20
particular individuals.<A name=3Dback2><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#go2">(=
2)</A></A>=20
By contrast, the term "research' designates an activity designed to test =
an=20
hypothesis, permit conclusions to be drawn, and thereby to develop or =
contribute=20
to generalizable knowledge (expressed, for example, in theories, =
principles, and=20
statements of relationships). Research is usually described in a formal =
protocol=20
that sets forth an objective and a set of procedures designed to reach =
that=20
objective.=20
<P>When a clinician departs in a significant way from standard or =
accepted=20
practice, the innovation does not, in and of itself, constitute =
research. The=20
fact that a procedure is "experimental," in the sense of new, untested =
or=20
different, does not automatically place it in the category of research.=20
Radically new procedures of this description should, however, be made =
the object=20
of formal research at an early stage in order to determine whether they =
are safe=20
and effective. Thus, it is the responsibility of medical practice =
committees,=20
for example, to insist that a major innovation be incorporated into a =
formal=20
research project.<A name=3Dback3><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#go3">(=
3)</A></A>=20

<P>Research and practice may be carried on together when research is =
designed to=20
evaluate the safety and efficacy of a therapy. This need not cause any =
confusion=20
regarding whether or not the activity requires review; the general rule =
is that=20
if there is any element of research in an activity, that activity should =
undergo=20
review for the protection of human subjects.<BR><BR>
<HR>

<H3>
<CENTER><A name=3Dxbasic>Part B: Basic Ethical =
Principles</A></CENTER></H3>
<P><B>B. Basic Ethical Principles</B>=20
<P>The expression "basic ethical principles" refers to those general =
judgments=20
that serve as a basic justification for the many particular ethical=20
prescriptions and evaluations of human actions. Three basic principles, =
among=20
those generally accepted in our cultural tradition, are particularly =
relevant to=20
the ethics of research involving human subjects: the principles of =
respect of=20
persons, beneficence and justice.=20
<P><B><A name=3Dxrespect>1. Respect for Persons.</A></B> -- Respect for =
persons=20
incorporates at least two ethical convictions: first, that individuals =
should be=20
treated as autonomous agents, and second, that persons with diminished =
autonomy=20
are entitled to protection. The principle of respect for persons thus =
divides=20
into two separate moral requirements: the requirement to acknowledge =
autonomy=20
and the requirement to protect those with diminished autonomy.=20
<P>An autonomous person is an individual capable of deliberation about =
personal=20
goals and of acting under the direction of such deliberation. To respect =

autonomy is to give weight to autonomous persons' considered opinions =
and=20
choices while refraining from obstructing their actions unless they are =
clearly=20
detrimental to others. To show lack of respect for an autonomous agent =
is to=20
repudiate that person's considered judgments, to deny an individual the =
freedom=20
to act on those considered judgments, or to withhold information =
necessary to=20
make a considered judgment, when there are no compelling reasons to do =
so.=20
<P>However, not every human being is capable of self-determination. The =
capacity=20
for self-determination matures during an individual's life, and some =
individuals=20
lose this capacity wholly or in part because of illness, mental =
disability, or=20
circumstances that severely restrict liberty. Respect for the immature =
and the=20
incapacitated may require protecting them as they mature or while they =
are=20
incapacitated.=20
<P>Some persons are in need of extensive protection, even to the point =
of=20
excluding them from activities which may harm them; other persons =
require little=20
protection beyond making sure they undertake activities freely and with=20
awareness of possible adverse consequence. The extent of protection =
afforded=20
should depend upon the risk of harm and the likelihood of benefit. The =
judgment=20
that any individual lacks autonomy should be periodically reevaluated =
and will=20
vary in different situations.=20
<P>In most cases of research involving human subjects, respect for =
persons=20
demands that subjects enter into the research voluntarily and with =
adequate=20
information. In some situations, however, application of the principle =
is not=20
obvious. The involvement of prisoners as subjects of research provides =
an=20
instructive example. On the one hand, it would seem that the principle =
of=20
respect for persons requires that prisoners not be deprived of the =
opportunity=20
to volunteer for research. On the other hand, under prison conditions =
they may=20
be subtly coerced or unduly influenced to engage in research activities =
for=20
which they would not otherwise volunteer. Respect for persons would then =
dictate=20
that prisoners be protected. Whether to allow prisoners to "volunteer" =
or to=20
"protect" them presents a dilemma. Respecting persons, in most hard =
cases, is=20
often a matter of balancing competing claims urged by the principle of =
respect=20
itself.=20
<P><B><A name=3Dxbenefit>2. Beneficence.</A></B> -- Persons are treated =
in an=20
ethical manner not only by respecting their decisions and protecting =
them from=20
harm, but also by making efforts to secure their well-being. Such =
treatment=20
falls under the principle of beneficence. The term "beneficence" is =
often=20
understood to cover acts of kindness or charity that go beyond strict=20
obligation. In this document, beneficence is understood in a stronger =
sense, as=20
an obligation. Two general rules have been formulated as complementary=20
expressions of beneficent actions in this sense: <B>(1)</B> do not harm =
and=20
<B>(2)</B> maximize possible benefits and minimize possible harms.=20
<P>The Hippocratic maxim "do no harm" has long been a fundamental =
principle of=20
medical ethics. Claude Bernard extended it to the realm of research, =
saying that=20
one should not injure one person regardless of the benefits that might =
come to=20
others. However, even avoiding harm requires learning what is harmful; =
and, in=20
the process of obtaining this information, persons may be exposed to =
risk of=20
harm. Further, the Hippocratic Oath requires physicians to benefit their =

patients "according to their best judgment." Learning what will in fact =
benefit=20
may require exposing persons to risk. The problem posed by these =
imperatives is=20
to decide when it is justifiable to seek certain benefits despite the =
risks=20
involved, and when the benefits should be foregone because of the risks. =

<P>The obligations of beneficence affect both individual investigators =
and=20
society at large, because they extend both to particular research =
projects and=20
to the entire enterprise of research. In the case of particular =
projects,=20
investigators and members of their institutions are obliged to give =
forethought=20
to the maximization of benefits and the reduction of risk that might =
occur from=20
the research investigation. In the case of scientific research in =
general,=20
members of the larger society are obliged to recognize the longer term =
benefits=20
and risks that may result from the improvement of knowledge and from the =

development of novel medical, psychotherapeutic, and social procedures.=20
<P>The principle of beneficence often occupies a well-defined justifying =
role in=20
many areas of research involving human subjects. An example is found in =
research=20
involving children. Effective ways of treating childhood diseases and =
fostering=20
healthy development are benefits that serve to justify research =
involving=20
children -- even when individual research subjects are not direct =
beneficiaries.=20
Research also makes it possible to avoid the harm that may result from =
the=20
application of previously accepted routine practices that on closer=20
investigation turn out to be dangerous. But the role of the principle of =

beneficence is not always so unambiguous. A difficult ethical problem =
remains,=20
for example, about research that presents more than minimal risk without =

immediate prospect of direct benefit to the children involved. Some have =
argued=20
that such research is inadmissible, while others have pointed out that =
this=20
limit would rule out much research promising great benefit to children =
in the=20
future. Here again, as with all hard cases, the different claims covered =
by the=20
principle of beneficence may come into conflict and force difficult =
choices.=20
<P><B><A name=3Dxjust>3. Justice.</A></B> -- Who ought to receive the =
benefits of=20
research and bear its burdens? This is a question of justice, in the =
sense of=20
"fairness in distribution" or "what is deserved." An injustice occurs =
when some=20
benefit to which a person is entitled is denied without good reason or =
when some=20
burden is imposed unduly. Another way of conceiving the principle of =
justice is=20
that equals ought to be treated equally. However, this statement =
requires=20
explication. Who is equal and who is unequal? What considerations =
justify=20
departure from equal distribution? Almost all commentators allow that=20
distinctions based on experience, age, deprivation, competence, merit =
and=20
position do sometimes constitute criteria justifying differential =
treatment for=20
certain purposes. It is necessary, then, to explain in what respects =
people=20
should be treated equally. There are several widely accepted =
formulations of=20
just ways to distribute burdens and benefits. Each formulation mentions =
some=20
relevant property on the basis of which burdens and benefits should be=20
distributed. These formulations are <B>(1)</B> to each person an equal =
share,=20
<B>(2)</B> to each person according to individual need, <B>(3)</B> to =
each=20
person according to individual effort, <B>(4)</B> to each person =
according to=20
societal contribution, and <B>(5)</B> to each person according to merit. =

<P>Questions of justice have long been associated with social practices =
such as=20
punishment, taxation and political representation. Until recently these=20
questions have not generally been associated with scientific research. =
However,=20
they are foreshadowed even in the earliest reflections on the ethics of =
research=20
involving human subjects. For example, during the 19th and early 20th =
centuries=20
the burdens of serving as research subjects fell largely upon poor ward=20
patients, while the benefits of improved medical care flowed primarily =
to=20
private patients. Subsequently, the exploitation of unwilling prisoners =
as=20
research subjects in Nazi concentration camps was condemned as a =
particularly=20
flagrant injustice. In this country, in the 1940's, the Tuskegee =
syphilis study=20
used disadvantaged, rural black men to study the untreated course of a =
disease=20
that is by no means confined to that population. These subjects were =
deprived of=20
demonstrably effective treatment in order not to interrupt the project, =
long=20
after such treatment became generally available.=20
<P>Against this historical background, it can be seen how conceptions of =
justice=20
are relevant to research involving human subjects. For example, the =
selection of=20
research subjects needs to be scrutinized in order to determine whether =
some=20
classes (e.g., welfare patients, particular racial and ethnic =
minorities, or=20
persons confined to institutions) are being systematically selected =
simply=20
because of their easy availability, their compromised position, or their =

manipulability, rather than for reasons directly related to the problem =
being=20
studied. Finally, whenever research supported by public funds leads to =
the=20
development of therapeutic devices and procedures, justice demands both =
that=20
these not provide advantages only to those who can afford them and that =
such=20
research should not unduly involve persons from groups unlikely to be =
among the=20
beneficiaries of subsequent applications of the research.<BR><BR>
<HR>

<H3>
<CENTER><A name=3Dxapp>Part C: Applications</A></CENTER></H3>
<P><B>C. Applications</B>=20
<P>Applications of the general principles to the conduct of research =
leads to=20
consideration of the following requirements: informed consent, =
risk/benefit=20
assessment, and the selection of subjects of research.=20
<P><B><A name=3Dxinform>1. Informed Consent.</A></B> -- Respect for =
persons=20
requires that subjects, to the degree that they are capable, be given =
the=20
opportunity to choose what shall or shall not happen to them. This =
opportunity=20
is provided when adequate standards for informed consent are satisfied.=20
<P>While the importance of informed consent is unquestioned, controversy =

prevails over the nature and possibility of an informed consent. =
Nonetheless,=20
there is widespread agreement that the consent process can be analyzed =
as=20
containing three elements: information, comprehension and voluntariness. =

<P><B>Information.</B> Most codes of research establish specific items =
for=20
disclosure intended to assure that subjects are given sufficient =
information.=20
These items generally include: the research procedure, their purposes, =
risks and=20
anticipated benefits, alternative procedures (where therapy is =
involved), and a=20
statement offering the subject the opportunity to ask questions and to =
withdraw=20
at any time from the research. Additional items have been proposed, =
including=20
how subjects are selected, the person responsible for the research, etc. =

<P>However, a simple listing of items does not answer the question of =
what the=20
standard should be for judging how much and what sort of information =
should be=20
provided. One standard frequently invoked in medical practice, namely =
the=20
information commonly provided by practitioners in the field or in the =
locale, is=20
inadequate since research takes place precisely when a common =
understanding does=20
not exist. Another standard, currently popular in malpractice law, =
requires the=20
practitioner to reveal the information that reasonable persons would =
wish to=20
know in order to make a decision regarding their care. This, too, seems=20
insufficient since the research subject, being in essence a volunteer, =
may wish=20
to know considerably more about risks gratuitously undertaken than do =
patients=20
who deliver themselves into the hand of a clinician for needed care. It =
may be=20
that a standard of "the reasonable volunteer" should be proposed: the =
extent and=20
nature of information should be such that persons, knowing that the =
procedure is=20
neither necessary for their care nor perhaps fully understood, can =
decide=20
whether they wish to participate in the furthering of knowledge. Even =
when some=20
direct benefit to them is anticipated, the subjects should understand =
clearly=20
the range of risk and the voluntary nature of participation.=20
<P>A special problem of consent arises where informing subjects of some=20
pertinent aspect of the research is likely to impair the validity of the =

research. In many cases, it is sufficient to indicate to subjects that =
they are=20
being invited to participate in research of which some features will not =
be=20
revealed until the research is concluded. In all cases of research =
involving=20
incomplete disclosure, such research is justified only if it is clear =
that=20
<B>(1)</B> incomplete disclosure is truly necessary to accomplish the =
goals of=20
the research, <B>(2)</B> there are no undisclosed risks to subjects that =
are=20
more than minimal, and <B>(3)</B> there is an adequate plan for =
debriefing=20
subjects, when appropriate, and for dissemination of research results to =
them.=20
Information about risks should never be withheld for the purpose of =
eliciting=20
the cooperation of subjects, and truthful answers should always be given =
to=20
direct questions about the research. Care should be taken to distinguish =
cases=20
in which disclosure would destroy or invalidate the research from cases =
in which=20
disclosure would simply inconvenience the investigator.=20
<P><B>Comprehension.</B> The manner and context in which information is =
conveyed=20
is as important as the information itself. For example, presenting =
information=20
in a disorganized and rapid fashion, allowing too little time for =
consideration=20
or curtailing opportunities for questioning, all may adversely affect a=20
subject's ability to make an informed choice.=20
<P>Because the subject's ability to understand is a function of =
intelligence,=20
rationality, maturity and language, it is necessary to adapt the =
presentation of=20
the information to the subject's capacities. Investigators are =
responsible for=20
ascertaining that the subject has comprehended the information. While =
there is=20
always an obligation to ascertain that the information about risk to =
subjects is=20
complete and adequately comprehended, when the risks are more serious, =
that=20
obligation increases. On occasion, it may be suitable to give some oral =
or=20
written tests of comprehension.=20
<P>Special provision may need to be made when comprehension is severely =
limited=20
-- for example, by conditions of immaturity or mental disability. Each =
class of=20
subjects that one might consider as incompetent (e.g., infants and young =

children, mentally disable patients, the terminally ill and the =
comatose) should=20
be considered on its own terms. Even for these persons, however, respect =

requires giving them the opportunity to choose to the extent they are =
able,=20
whether or not to participate in research. The objections of these =
subjects to=20
involvement should be honored, unless the research entails providing =
them a=20
therapy unavailable elsewhere. Respect for persons also requires seeking =
the=20
permission of other parties in order to protect the subjects from harm. =
Such=20
persons are thus respected both by acknowledging their own wishes and by =
the use=20
of third parties to protect them from harm.=20
<P>The third parties chosen should be those who are most likely to =
understand=20
the incompetent subject's situation and to act in that person's best =
interest.=20
The person authorized to act on behalf of the subject should be given an =

opportunity to observe the research as it proceeds in order to be able =
to=20
withdraw the subject from the research, if such action appears in the =
subject's=20
best interest.=20
<P><B>Voluntariness.</B> An agreement to participate in research =
constitutes a=20
valid consent only if voluntarily given. This element of informed =
consent=20
requires conditions free of coercion and undue influence. Coercion =
occurs when=20
an overt threat of harm is intentionally presented by one person to =
another in=20
order to obtain compliance. Undue influence, by contrast, occurs through =
an=20
offer of an excessive, unwarranted, inappropriate or improper reward or =
other=20
overture in order to obtain compliance. Also, inducements that would =
ordinarily=20
be acceptable may become undue influences if the subject is especially=20
vulnerable.=20
<P>Unjustifiable pressures usually occur when persons in positions of =
authority=20
or commanding influence -- especially where possible sanctions are =
involved --=20
urge a course of action for a subject. A continuum of such influencing =
factors=20
exists, however, and it is impossible to state precisely where =
justifiable=20
persuasion ends and undue influence begins. But undue influence would =
include=20
actions such as manipulating a person's choice through the controlling =
influence=20
of a close relative and threatening to withdraw health services to which =
an=20
individual would otherwise be entitle.=20
<P><B><A name=3Dxassess>2. Assessment of Risks and Benefits.</A></B> -- =
The=20
assessment of risks and benefits requires a careful arrayal of relevant =
data,=20
including, in some cases, alternative ways of obtaining the benefits =
sought in=20
the research. Thus, the assessment presents both an opportunity and a=20
responsibility to gather systematic and comprehensive information about =
proposed=20
research. For the investigator, it is a means to examine whether the =
proposed=20
research is properly designed. For a review committee, it is a method =
for=20
determining whether the risks that will be presented to subjects are =
justified.=20
For prospective subjects, the assessment will assist the determination =
whether=20
or not to participate.=20
<P><B>The Nature and Scope of Risks and Benefits.</B> The requirement =
that=20
research be justified on the basis of a favorable risk/benefit =
assessment bears=20
a close relation to the principle of beneficence, just as the moral =
requirement=20
that informed consent be obtained is derived primarily from the =
principle of=20
respect for persons. The term "risk" refers to a possibility that harm =
may=20
occur. However, when expressions such as "small risk" or "high risk" are =
used,=20
they usually refer (often ambiguously) both to the chance (probability) =
of=20
experiencing a harm and the severity (magnitude) of the envisioned harm. =

<P>The term "benefit" is used in the research context to refer to =
something of=20
positive value related to health or welfare. Unlike, "risk," "benefit" =
is not a=20
term that expresses probabilities. Risk is properly contrasted to =
probability of=20
benefits, and benefits are properly contrasted with harms rather than =
risks of=20
harm. Accordingly, so-called risk/benefit assessments are concerned with =
the=20
probabilities and magnitudes of possible harm and anticipated benefits. =
Many=20
kinds of possible harms and benefits need to be taken into account. =
There are,=20
for example, risks of psychological harm, physical harm, legal harm, =
social harm=20
and economic harm and the corresponding benefits. While the most likely =
types of=20
harms to research subjects are those of psychological or physical pain =
or=20
injury, other possible kinds should not be overlooked.=20
<P>Risks and benefits of research may affect the individual subjects, =
the=20
families of the individual subjects, and society at large (or special =
groups of=20
subjects in society). Previous codes and Federal regulations have =
required that=20
risks to subjects be outweighed by the sum of both the anticipated =
benefit to=20
the subject, if any, and the anticipated benefit to society in the form =
of=20
knowledge to be gained from the research. In balancing these different =
elements,=20
the risks and benefits affecting the immediate research subject will =
normally=20
carry special weight. On the other hand, interests other than those of =
the=20
subject may on some occasions be sufficient by themselves to justify the =
risks=20
involved in the research, so long as the subjects' rights have been =
protected.=20
Beneficence thus requires that we protect against risk of harm to =
subjects and=20
also that we be concerned about the loss of the substantial benefits =
that might=20
be gained from research.=20
<P><B>The Systematic Assessment of Risks and Benefits.</B> It is =
commonly said=20
that benefits and risks must be "balanced" and shown to be "in a =
favorable=20
ratio." The metaphorical character of these terms draws attention to the =

difficulty of making precise judgments. Only on rare occasions will =
quantitative=20
techniques be available for the scrutiny of research protocols. However, =
the=20
idea of systematic, nonarbitrary analysis of risks and benefits should =
be=20
emulated insofar as possible. This ideal requires those making decisions =
about=20
the justifiability of research to be thorough in the accumulation and =
assessment=20
of information about all aspects of the research, and to consider =
alternatives=20
systematically. This procedure renders the assessment of research more =
rigorous=20
and precise, while making communication between review board members and =

investigators less subject to misinterpretation, misinformation and =
conflicting=20
judgments. Thus, there should first be a determination of the validity =
of the=20
presuppositions of the research; then the nature, probability and =
magnitude of=20
risk should be distinguished with as much clarity as possible. The =
method of=20
ascertaining risks should be explicit, especially where there is no =
alternative=20
to the use of such vague categories as small or slight risk. It should =
also be=20
determined whether an investigator's estimates of the probability of =
harm or=20
benefits are reasonable, as judged by known facts or other available =
studies.=20
<P>Finally, assessment of the justifiability of research should reflect =
at least=20
the following considerations: <B>(i)</B> Brutal or inhumane treatment of =
human=20
subjects is never morally justified. <B>(ii)</B> Risks should be reduced =
to=20
those necessary to achieve the research objective. It should be =
determined=20
whether it is in fact necessary to use human subjects at all. Risk can =
perhaps=20
never be entirely eliminated, but it can often be reduced by careful =
attention=20
to alternative procedures. <B>(iii)</B> When research involves =
significant risk=20
of serious impairment, review committees should be extraordinarily =
insistent on=20
the justification of the risk (looking usually to the likelihood of =
benefit to=20
the subject -- or, in some rare cases, to the manifest voluntariness of =
the=20
participation). <B>(iv)</B> When vulnerable populations are involved in=20
research, the appropriateness of involving them should itself be =
demonstrated. A=20
number of variables go into such judgments, including the nature and =
degree of=20
risk, the condition of the particular population involved, and the =
nature and=20
level of the anticipated benefits. <B>(v)</B> Relevant risks and =
benefits must=20
be thoroughly arrayed in documents and procedures used in the informed =
consent=20
process.=20
<P><B><A name=3Dxselect>3. Selection of Subjects.</A></B> -- Just as the =
principle=20
of respect for persons finds expression in the requirements for consent, =
and the=20
principle of beneficence in risk/benefit assessment, the principle of =
justice=20
gives rise to moral requirements that there be fair procedures and =
outcomes in=20
the selection of research subjects.=20
<P>Justice is relevant to the selection of subjects of research at two =
levels:=20
the social and the individual. Individual justice in the selection of =
subjects=20
would require that researchers exhibit fairness: thus, they should not =
offer=20
potentially beneficial research only to some patients who are in their =
favor or=20
select only "undesirable" persons for risky research. Social justice =
requires=20
that distinction be drawn between classes of subjects that ought, and =
ought not,=20
to participate in any particular kind of research, based on the ability =
of=20
members of that class to bear burdens and on the appropriateness of =
placing=20
further burdens on already burdened persons. Thus, it can be considered =
a matter=20
of social justice that there is an order of preference in the selection =
of=20
classes of subjects (e.g., adults before children) and that some classes =
of=20
potential subjects (e.g., the institutionalized mentally infirm or =
prisoners)=20
may be involved as research subjects, if at all, only on certain =
conditions.=20
<P>Injustice may appear in the selection of subjects, even if individual =

subjects are selected fairly by investigators and treated fairly in the =
course=20
of research. Thus injustice arises from social, racial, sexual and =
cultural=20
biases institutionalized in society. Thus, even if individual =
researchers are=20
treating their research subjects fairly, and even if IRBs are taking =
care to=20
assure that subjects are selected fairly within a particular =
institution, unjust=20
social patterns may nevertheless appear in the overall distribution of =
the=20
burdens and benefits of research. Although individual institutions or=20
investigators may not be able to resolve a problem that is pervasive in =
their=20
social setting, they can consider distributive justice in selecting =
research=20
subjects.=20
<P>Some populations, especially institutionalized ones, are already =
burdened in=20
many ways by their infirmities and environments. When research is =
proposed that=20
involves risks and does not include a therapeutic component, other less =
burdened=20
classes of persons should be called upon first to accept these risks of=20
research, except where the research is directly related to the specific=20
conditions of the class involved. Also, even though public funds for =
research=20
may often flow in the same directions as public funds for health care, =
it seems=20
unfair that populations dependent on public health care constitute a =
pool of=20
preferred research subjects if more advantaged populations are likely to =
be the=20
recipients of the benefits.=20
<P>One special instance of injustice results from the involvement of =
vulnerable=20
subjects. Certain groups, such as racial minorities, the economically=20
disadvantaged, the very sick, and the institutionalized may continually =
be=20
sought as research subjects, owing to their ready availability in =
settings where=20
research is conducted. Given their dependent status and their frequently =

compromised capacity for free consent, they should be protected against =
the=20
danger of being involved in research solely for administrative =
convenience, or=20
because they are easy to manipulate as a result of their illness or=20
socioeconomic condition.<BR><BR>
<HR>

<P><A name=3Dgo1><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#back1"=
>(1)</A></A>=20
Since 1945, various codes for the proper and responsible conduct of =
human=20
experimentation in medical research have been adopted by different=20
organizations. The best known of these codes are the Nuremberg Code of =
1947, the=20
Helsinki Declaration of 1964 (revised in 1975), and the 1971 Guidelines=20
(codified into Federal Regulations in 1974) issued by the U.S. =
Department of=20
Health, Education, and Welfare Codes for the conduct of social and =
behavioral=20
research have also been adopted, the best known being that of the =
American=20
Psychological Association, published in 1973.=20
<P><A name=3Dgo2><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#back2"=
>(2)</A></A>=20
Although practice usually involves interventions designed solely to =
enhance the=20
well-being of a particular individual, interventions are sometimes =
applied to=20
one individual for the enhancement of the well-being of another (e.g., =
blood=20
donation, skin grafts, organ transplants) or an intervention may have =
the dual=20
purpose of enhancing the well-being of a particular individual, and, at =
the same=20
time, providing some benefit to others (e.g., vaccination, which =
protects both=20
the person who is vaccinated and society generally). The fact that some =
forms of=20
practice have elements other than immediate benefit to the individual =
receiving=20
an intervention, however, should not confuse the general distinction =
between=20
research and practice. Even when a procedure applied in practice may =
benefit=20
some other person, it remains an intervention designed to enhance the =
well-being=20
of a particular individual or groups of individuals; thus, it is =
practice and=20
need not be reviewed as research.=20
<P><A name=3Dgo3><A=20
href=3D"http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm#back3"=
>(3)</A></A>=20
Because the problems related to social experimentation may differ =
substantially=20
from those of biomedical and behavioral research, the Commission =
specifically=20
declines to make any policy determination regarding such research at =
this time.=20
Rather, the Commission believes that the problem ought to be addressed =
by one of=20
its successor bodies.<BR><BR>
<HR>
<!--"TimeStamp" endspan =
i-checksum=3D"11125"--></FONT></EM></TD></BODY></HTML>

